U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07068906) titled 'A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma' on July 07.
Brief Summary: A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1194C CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell NonHodgkin Lymphoma.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
B-Cell Non-Hodgkin Lymphoma
Intervention:
DRUG: CAR-T cells chimenric antigen receptor T cells
CT1194C cells infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Published by HT Digital Content Services ...